Publications by authors named "Charles Shaefer"

Claim this Profile
W
When basal insulin is not enough: response to M Davidson.
Guillermo E Umpierrez, Neil Skolnik, Terry Dex, Louise Traylor, Jason Chao, Charles Shaefer

Diabetes Obes Metab· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control.
Guillermo E Umpierrez, Neil Skolnik, Terry Dex, Louise Traylor, Jason Chao, Charles Shaefer

Diabetes Obes Metab· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Guillermo E Umpierrez, Timothy S Bailey, Danielle Carcia, Charles Shaefer, Jay H Shubrook

J Diabetes· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus.
John E Anderson, Eugene E Wright, Charles F Shaefer

Diabetes Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia and diabetes: increased need for awareness.
Charles Shaefer, Debbie Hinnen, Christopher Sadler

Curr Med Res Opin· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes.
James J Chamberlain, Andrew S Rhinehart, Charles F Shaefer, Annie Neuman

Ann Intern Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.
Charles F Shaefer

Clin Diabetes· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
User's guide to mechanism of action and clinical use of GLP-1 receptor agonists.
Charles F Shaefer, Pamela Kushner, Richard Aguilar

Postgrad Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Charles F Shaefer, John Anderson

Postgrad Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
Charles Shaefer, Timothy Reid, Aleksandra Vlajnic, Rong Zhou, Andres DiGenio

Endocr Pract· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences.
Charles Shaefer, Timothy Reid, Andres DiGenio, Aleksandra Vlajnic, Rong Zhou

Diabetes Metab Res Rev· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.
Charles F Shaefer, Timothy S Reid, George Dailey, Melanie E Mabrey, Aleksandra Vlajnic

Postgrad Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis